CD19 and hereditary disease: We used evoCAST to install human factor IX cDNA into ALB intron 1; to insert a CD19-targeted chimeric antigen receptor into TRAC; and to integrate wild-type cDNAs of four genes implicated in loss-of-function genetic diseases into intron 1 of their respective endogenous loci.